Regeneron Pharmaceuticals Inc. buy Piper Sandler
Start price
23.08.24
/
50%
€1,072.0
Target price
23.08.25
€1,109.7
Performance (%)
-53.25%
End price
24.08.25
€501.20
Summary
This prediction ended on 24.08.25 with a price of €501.20. The BUY prediction by Piper_Sandler for Regeneron Pharmaceuticals Inc. performed very badly with a performance of -53.25%. Piper_Sandler has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €2.60 are taken into consideration when calculating the performance. Piper_Sandler has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -3.506% | -3.506% | 31.240% |
| iShares Core DAX® | 0.789% | 1.975% | 13.390% |
| iShares Nasdaq 100 | 4.226% | 4.344% | 39.717% |
| iShares Nikkei 225® | 3.285% | 6.991% | 49.894% |
| iShares S&P 500 | 2.496% | 2.759% | 30.229% |
Comments by Piper_Sandler for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at Piper Sandler from $1,166.00 to $1,242.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€666.40
31.03.26
31.03.26
€762.30
31.03.27
31.03.27
-5.00%
16.04.26
16.04.26
Stopped prediction by Piper_Sandler for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€652.60
27.01.25
27.01.25
€964.27
27.01.26
27.01.26
-1.93%
28.01.26
28.01.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€780.20
01.11.24
01.11.24
€1,099.4
01.11.25
01.11.25
-27.20%
02.11.25
02.11.25